Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not receive GLP-1 agonists
Without a transporter, they remain blocked in the cytoplasm and cannot be burned to produce energy
Morphew, Aberystwyth University, United Kingdom Updates Copyright 2022 Chen, Liu, Cheng, Cui, Wang and Zhang
A: Some individuals may experience temporary side effects like mild nausea, dizziness, or headaches, though these symptoms typically resolve on their own
Penberthy KK, Ravichandran KS